IP tax strategies come under fire from US senators
Legislators put pharma companies under the microscope and blame a law signed by President Trump in 2017 for patent-based payment mitigation
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.